Evidence map›Paper›PMID 23243445›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2012

Randomized Clinical Trial on the Use of PHYSTA Freeze-Dried Water Extract of Eurycoma longifolia for the Improvement of Quality of Life and Sexual Well-Being in Men.

Shaiful Bahari Ismail, Wan Mohd Zahiruddin Wan Mohammad, Annie George, Nik Hazlina Nik Hussain, Zatul Mufiza Musthapa Kamal, Eckehard Liske

Registry-linked trialAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05347329 (A Phase II, Randomized, Double Blind, Placebo-Controlled, Three-arm, Multi-center Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus for the Improvement of Sexual Well-being and Quality of Life in Men), which is not on this map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05347329 nacompletednot on this mapstarted 2019, after this paper: background citation

A Phase II, Randomized, Double Blind, Placebo-Controlled, Three-arm, Multi-center Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus for the Improvement of Sexual Well-being and Quality of Life in Men

TypeinterventionalSponsorNatural Wellness EgyptRan2019 to 2020Enrolled197ConditionsErectile DysfunctionArmsTongkat Ali Maca Plus
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Medicina (Kaunas, Lithuania) · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. A systematic appraisal of emerging alternative therapies in men's health and wellness.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
  6. Effects ofBMJ open · 2023
    Article
  7. Review
  8. How Internet Websites Portray Herbal Vitality Products ContainingInternational journal of environmental research and public health · 2022
    Article
  9. A review on extraction techniques and therapeutic value of polar bioactives from Asian medicinal herbs: Case study onSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  10. Effect ofFood & nutrition research · 2021
    Article
  11. Review
  12. Article
  13. Efficacy and safety ofFood & nutrition research · 2018
    Article
  14. Effects of Root Extracts of Eurycoma longifolia Jack on Corpus Cavernosum of Rat.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2017
    Article
  15. Review
  16. First Report ofBioMed research international · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shaiful Bahari IsmailSchool of Medical Sciences, Universiti Sains Malaysia, Kelantan, 16150 Kubang Kerian, Malaysia.
Wan Mohd Zahiruddin Wan Mohammad
Annie George
Nik Hazlina Nik Hussain
Zatul Mufiza Musthapa Kamal
Eckehard Liske

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eurycoma longifolia is reputed as an aphrodisiac and remedy for decreased male libido. A randomized, double-blind, placebo controlled, parallel group study was carried out to investigate the clinical evidence of E. longifolia in men. The 12-week study in 109 men between 30 and 55 years of age consisted of either treatment of 300 mg of water extract of E. longifolia (Physta) or placebo. Primary endpoints were the Quality of Life investigated by SF-36 questionnaire and Sexual Well-Being investigated by International Index of Erectile Function (IIEF) and Sexual Health Questionnaires (SHQ); Seminal Fluid Analysis (SFA), fat mass and safety profiles. Repeated measures ANOVA analysis was used to compare changes in the endpoints. The E. longifolia (EL) group significantly improved in the domain Physical Functioning of SF-36, from baseline to week 12 compared to placebo (P = 0.006) and in between group at week 12 (P = 0.028). The EL group showed higher scores in the overall Erectile Function domain in IIEF (P < 0.001), sexual libido (14% by week 12), SFA- with sperm motility at 44.4%, and semen volume at 18.2% at the end of treatment. Subjects with BMI ≥ 25 kg/m(2) significantly improved in fat mass lost (P = 0.008). All safety parameters were comparable to placebo.

Identifiers

PMID23243445
PMCPMC3518798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.